AFA
HALO icon

Abacus FCF Advisors’s Halozyme HALO Stock Holding History

Abacus FCF Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-40,649
Closed -$2.33M – 283
2024
Q3 		$2.33M Sell
40,649
-7,280
-15% -$417K 0.54% 69
2024
Q2 		$2.51M Buy
47,929
+26,765
+126% +$1.17M 0.62% 49
2024
Q1 		$861K Buy
21,164
+391
+2% +$14.7K 0.22% 127
2023
Q4 		$768K Buy
20,773
+16,864
+431% +$635K 0.22% 124
2023
Q3 		$149K Buy
+3,909
New +$160K 0.08% 138

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Abacus FCF Advisors's HALO Position: Q4 2024 in Review

Abacus FCF Advisors sold out of Halozyme (HALO) in Q4 2024, closing a stake of 40,649 shares — an estimated $2.33M sold.

Abacus FCF Advisors first reported a position in HALO in Q3 2023 and held it in 5 quarters. The position peaked at $2.51M in Q2 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Abacus FCF Advisors reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Abacus FCF Advisors sold 40,649 Halozyme shares in Q4 2024, an estimated $2.33M.
  • Abacus FCF Advisors first reported a position in Halozyme in Q3 2023 and held it in 5 quarters.
  • Abacus FCF Advisors's Halozyme position peaked at $2.51M in Q2 2024.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Abacus FCF Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.